PRODUCT PROFILE

Latest Dublin Prices

NAME
LATEST
CHANGE
Aer Lingus 1.70 0.02 more
BoI 0.31 0.00 more
CRH 18.70 0.22 more
Glanbia 11.82 0.02 more
Greencore 0.64 -0.02 more
Ind. News 0.12 0.01 more
Ryanair 8.46 0.05 more

 

Kite Pharma's lead cancer therapy

Tuesday, August 26 09:44:15

Drug developer Kite Pharma Inc said its experimental cancer therapy showed potential in treating patients in an early-stage study.

The company's lead drug, KTE-C19, is being developed to fight an aggressive form of blood cancer.

The immunotherapy involves genetically modifying a patient's cells to target a protein found on the surface of some lymphoma and leukemia cells.

Kite's shares were up 35.2 percent at $30.15 in extended trading. (Reuters)

For more visit: www.businessworld.ie